These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27199033)

  • 1. Effects of CYP2C19 variants on methadone metabolism in vitro.
    Lan T; Yuan LJ; Hu XX; Zhou Q; Wang J; Huang XX; Dai DP; Cai JP; Hu GX
    Drug Test Anal; 2017 Apr; 9(4):634-639. PubMed ID: 27199033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment of 24 CYP2D6 allelic isoforms on the metabolism of methadone.
    Su Y; Zhan YY; Wang BF; Wang SC; Dai DP; Hu GX; Lin H; Lian QQ; Cai JP
    Drug Test Anal; 2017 Feb; 9(2):216-220. PubMed ID: 26968424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CYP2C19 variants on the metabolism of tapentadol
    Xu RA; Fang P; Ye Z; Han M; Cai JP; Hu GX
    Iran J Basic Med Sci; 2022 May; 25(5):659-663. PubMed ID: 35911647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 31 recombinant CYP2C19 variants on clomipramine metabolism in vitro.
    Lan T; Ma YQ; Dang YM; Wang CC; Xu RA; Cai JP; Hu GX
    J Psychopharmacol; 2021 Dec; 35(12):1517-1522. PubMed ID: 34702100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of CYP2C19 Variants on Fluoxetine Metabolism in vitro.
    Fang P; He JY; Han AX; Lan T; Dai DP; Cai JP; Hu GX
    Pharmacology; 2017; 100(1-2):91-97. PubMed ID: 28494448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro.
    Xu RA; Gu EM; Liu TH; Ou-Yang QG; Hu GX; Cai JP
    Infect Drug Resist; 2018; 11():2129-2135. PubMed ID: 30464555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
    Gerber JG; Rhodes RJ; Gal J
    Chirality; 2004 Jan; 16(1):36-44. PubMed ID: 14628297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.
    Zhou XY; Hu XX; Li MF; Wang H; Zhang LQ; Hu GX; Cai JP
    Drug Test Anal; 2018 May; 10(5):807-813. PubMed ID: 29098786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Functional Characterisation of Cytochrome P450 (CYP) 2C19 Allelic Variants CYP2C19*23 and CYP2C19*24.
    Lau PS; Leong KV; Ong CE; Dong AN; Pan Y
    Biochem Genet; 2017 Feb; 55(1):48-62. PubMed ID: 27578295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cytochrome P450 2C9 polymorphism on bosentan metabolism.
    Chen M; Zhang Y; Pan P; Wang L; Zhan Y; Jin H; Xia M; Wang X; Dai D; Cai J; Hu G
    Drug Metab Dispos; 2014 Nov; 42(11):1820-5. PubMed ID: 25142737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional assessment of CYP3A4 and CYP2C19 genetic polymorphisms on the metabolism of clothianidin invitro.
    Hu Y; Ye Z; Wu H; Chen X; Xia H; Cai JP; Hu GX; Xu RA
    Chem Biol Interact; 2024 Aug; 399():111154. PubMed ID: 39025286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study.
    Carlquist JF; Moody DE; Knight S; Johnson EG; Fang WB; Huntinghouse JA; Rollo JS; Webster LR; Anderson JL
    Mol Diagn Ther; 2015 Apr; 19(2):131-8. PubMed ID: 25903311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of CYP450 genetic variability effect on methadone dose and tolerance.
    Tsai HJ; Wang SC; Liu SW; Ho IK; Chang YS; Tsai YT; Lin KM; Liu YL
    Pharmacogenomics; 2014 May; 15(7):977-86. PubMed ID: 24956251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Methadone Metabolism by CYP2B6 Variants.
    Gadel S; Friedel C; Kharasch ED
    Drug Metab Dispos; 2015 Jul; 43(7):994-1001. PubMed ID: 25897175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro.
    Fang P; Zheng X; He J; Ge H; Tang P; Cai J; Hu G
    Drug Des Devel Ther; 2017; 11():1283-1290. PubMed ID: 28461741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro approach to potential methadone metabolic-inhibition interactions.
    Bomsien S; Skopp G
    Eur J Clin Pharmacol; 2007 Sep; 63(9):821-7. PubMed ID: 17598095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokkar M; Gothuey I; Hämmig R; Monnat M; Hüttemann H; Baumann P; Eap CB
    Clin Pharmacol Ther; 2005 Dec; 78(6):593-604. PubMed ID: 16338275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of 38 variants CYP2C9 polymorphism on ketamine metabolism in vitro.
    Zheng X; Fang P; Bao SS; Lin D; Cai JP; Hu GX
    J Pharmacol Sci; 2017 Sep; 135(1):8-13. PubMed ID: 28927781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CYP2D6 genetic polymorphism on the metabolism of citalopram in vitro.
    Hu XX; Yuan LJ; Fang P; Mao YH; Zhan YY; Li XY; Dai DP; Cai JP; Hu GX
    Drug Metab Pharmacokinet; 2016 Apr; 31(2):133-8. PubMed ID: 27016952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 24 CYP2D6 Variants on the Metabolism of Nebivolol In Vitro.
    Hu X; Lan T; Dai D; Xu RA; Yuan L; Zhou Q; Li Y; Cai J; Hu G
    Drug Metab Dispos; 2016 Nov; 44(11):1828-1831. PubMed ID: 27538917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.